The regulatory proteins, such as proline-, glutamic acid-, and leucine-rich protein 1 (PELP1) and proto-oncogene tyrosine-protein kinase c-Src (SRC), can modify cell signaling pathways influenced by estrogen, leading to proliferation, differentiation, or survival of the cancer cells [34,35]. This evidence concerns the gene SRC and cancer.